IPSEN : Innovation for patient care

  • The Ipsen Group

Info

Ipsen Pty Ltd

Focus

About Ipsen Pty Ltd

Ipsen Pty Ltd is the Australian affiliate of a European pharmaceutical group. Globally Ipsen focuses on developing highly specialised products to meet specific needs in therapeutic areas such as oncology, endocrinology and neuromuscular disorders. Ipsen has research and development facilities in Paris, London, Boston and Barcelona.

Our Products

Dysport® - Clostridium botulinum type A toxin-haemagglutinin complex

CMI


NutropinAq® - Somatropin, recombinant DNA origin, Escherichia coli

CMI


Somatuline® autogel® - lanreotide

CMI


Somatuline® LA - lanreotide

CMI



The material provided on this website is for your information only and does not replace the advice provided by your doctor and/or pharmacist. If you have any questions or require advice about medicines that you have been prescribed, please discuss these with your doctor or pharmacist. The information provided on this page is intended for use in Australia only.

Please carefully read the website Terms as they determine the conditions of use of this site which you accept and agree by consulting and using our site. If you do not accept these Terms, we ask you to leave our site.

Address